This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Ventricular Tachycardia
and you are
between 18 and 85
years old
The phase for this study is not defined.
Show me locations

The purpose

The objective of this trial is to determine the efficacy and safety of adjunctive catheter-based renal sympathetic denervation (RSDN) in the primary prevention of ICD therapy in patients with ischemic or non-ischemic ventricular dysfunction, who are to receive an ICD for either i) secondary prevention, or ii) primary prevention + inducible VT by programmed ventricular stimulation at the time of ICD implantation. These patients will be randomized to ICD alone or ICD + RSDN.

Provided treatments

  • Device: Boston Scientific Vessix Renal Denervation System

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01747837. The sponsor of the trial is Vivek Reddy and it is looking for 462 volunteers for the current phase.
Official trial title:
REnal SympathetiC Denervation to sUpprEss Tachyarrhythmias in ICD Recipients